Patents by Inventor Suttipun Sungsuwan

Suttipun Sungsuwan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINE AND THERAPEUTIC COMPOSITIONS COMPRISING ANTIGEN-CONJUGATED VIRAL CAPSIDS
    Publication number: 20230256080
    Abstract: Provided herein are vaccine composition comprising a bovine leukemia virus (BLV) antigen conjugated to a capsid, wherein the capsid comprises wild type or native sequence. Provided herein are also vaccine composition comprising a BLV antigen conjugated to a capsid, wherein said capsid comprises at least one mutation, such as a non-natural mutation. Such compositions are useful in the treatment and prevention of BLV infection and associated sequelae, e.g. cancer, immunosuppressive, and inflammatory diseases.
    Type: Application
    Filed: April 4, 2022
    Publication date: August 17, 2023
    Inventors: Xuefei Huang, Suttipun Sungsuwan, Shivangi Chugh, Vilma Yuzbasiyan-Gurkan, Cheryl L. Swenson
  • Vaccine and therapeutic compositions comprising antigen-conjugated viral capsids
    Patent number: 11576957
    Abstract: Provided herein are vaccine composition comprising an antigen conjugated to a capsid, wherein the capsid comprises wild type or native sequence. Provided herein are also vaccine composition comprising an antigen conjugated to a capsid, wherein said capsid comprises at least one mutation, such as a non-natural mutation. Such compositions are useful in the treatment and prevention of pathogenic infections, inflammatory diseases, and neurodegenerative disease, and cancer, among others.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: February 14, 2023
    Assignee: Board of Trustees of Michigan State University
    Inventors: Xuefei Huang, Suttipun Sungsuwan
  • COMPOSITIONS AND METHODS OF TREATING CANCER AND INFECTIONS USING BACTERIOPHAGE AND ITS MUTANTS
    Publication number: 20200261559
    Abstract: Provided herein are vaccine composition comprising an antigen conjugated to a capsid, wherein the capsid comprises wild type or native sequence. Provided herein are also vaccine composition comprising an antigen conjugated to a capsid, wherein said capsid comprises at least one mutation, such as a non-natural mutation. Such compositions are useful in the treatment and prevention of pathogenic infections, inflammatory diseases, and neurodegenerative disease, and cancer, among others.
    Type: Application
    Filed: April 23, 2018
    Publication date: August 20, 2020
    Applicant: Board of Trustees of Michigan State University
    Inventors: Xuefei Huang, Suttipun Sungsuwan